Mark Oldham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Oldham has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
- John Adamovics
Department of Chemistry and Biology, Rider University, Skillman, NJ
15 shared publications Andrew Thomas
Duke University Medical Center, Durham, North Carolina 27710
7 shared publicationsJohn Adamovics
Rider University, Lawrenceville, NJ, 08648, USA
7 shared publicationsTitania Juang
Duke University Medical Physics Graduate Program, Durham, North Carolina 27705
5 shared publicationsDavid G. Kirsch
Department of Radiation Oncology Duke University Medical Center Durham NC 27708 USA
4 shared publicationsJacob Kodra
Physics Division, Department of Radiation Oncology, Duke University Medical Center, Trent Drive, Durham, NC, 27710, USA
4 shared publications
Latest Publications
- 10 October 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (3) , 759-764
Investigating the FLASH Effect in a Rat Brain Organotypic Model With a Novel High-Energy Electron Beam
- 10 October 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (3) , 759-764
Investigating the FLASH Effect in a Rat Brain Organotypic Model With a Novel High-Energy Electron Beam
- Open Access
The Effect of Atm Loss on Radiosensitivity of a Primary Mouse Model of Pten-Deleted Brainstem Glioma
Diffuse midline gliomas arise in the brainstem and other midline brain structures and cause a large proportion of childhood brain tumor deaths. Radiation therapy is the most effective treatment option, but these tumors ultimately progress. Inhibition of the phosphoinositide-3-kinase (PI3K)-like kinase, ataxia–telangiectasia mutated (ATM), which orchestrates the cellular response to radiation-induced DNA damage, may enhance the efficacy of radiation therapy. Diffuse midline gliomas in the brainstem contain loss-of-function mutations in the tumor suppressor PTEN, or functionally similar alterations in the phosphoinositide-3-kinase (PI3K) pathway, at moderate frequency. Here, we sought to determine if ATM inactivation could radiosensitize a primary mouse model of brainstem glioma driven by Pten loss. Using Cre/loxP recombinase technology and the RCAS/TVA retroviral gene delivery system, we established a mouse model of brainstem glioma driven by Pten deletion. We find that Pten-null brainstem gliomas are relatively radiosensitive at baseline. In addition, we show that deletion of Atm in the tumor cells does not extend survival of mice bearing Pten-null brainstem gliomas after focal brain irradiation. These results characterize a novel primary mouse model of PTEN-mutated brainstem glioma and provide insights into the mechanism of radiosensitization by ATM deletion, which may guide the design of future clinical trials.
Open AccessThe Effect of Atm Loss on Radiosensitivity of a Primary Mouse Model of Pten-Deleted Brainstem Glioma
Diffuse midline gliomas arise in the brainstem and other midline brain structures and cause a large proportion of childhood brain tumor deaths. Radiation therapy is the most effective treatment option, but these tumors ultimately progress. Inhibition of the phosphoinositide-3-kinase (PI3K)-like kinase, ataxia–telangiectasia mutated (ATM), which orchestrates the cellular response to radiation-induced DNA damage, may enhance the efficacy of radiation therapy. Diffuse midline gliomas in the brainstem contain loss-of-function mutations in the tumor suppressor PTEN, or functionally similar alterations in the phosphoinositide-3-kinase (PI3K) pathway, at moderate frequency. Here, we sought to determine if ATM inactivation could radiosensitize a primary mouse model of brainstem glioma driven by Pten loss. Using Cre/loxP recombinase technology and the RCAS/TVA retroviral gene delivery system, we established a mouse model of brainstem glioma driven by Pten deletion. We find that Pten-null brainstem gliomas are relatively radiosensitive at baseline. In addition, we show that deletion of Atm in the tumor cells does not extend survival of mice bearing Pten-null brainstem gliomas after focal brain irradiation. These results characterize a novel primary mouse model of PTEN-mutated brainstem glioma and provide insights into the mechanism of radiosensitization by ATM deletion, which may guide the design of future clinical trials.
- 18 February 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (4) , 045017
An investigation of kV mini-GRID spatially fractionated radiation therapy: dosimetry and preclinical trial
Objective . To develop and characterize novel methods of extreme spatially fractionated kV radiation therapy (including mini-GRID therapy) and to evaluate efficacy in the context of a pre-clinical mouse study. Approach . Spatially fractionated GRIDs were precision-milled from 3 mm thick lead sheets compatible with mounting on a 225 kVp small animal irradiator (X-Rad). Three pencil-beam GRIDs created arrays of 1 mm diameter beams, and three ‘bar’ GRIDs created 1 × 20 mm rectangular fields. GRIDs projected 20 × 20 mm 2 fields at isocenter, and beamlets were spaced at 1, 1.25, and 1.5 mm, respectively. Peak-to-valley ratios and dose distributions were evaluated with Gafchromic film. Syngeneic transplant tumors were induced by intramuscular injection of a soft tissue sarcoma cell line into the gastrocnemius muscle of C57BL/6 mice. Tumor-bearing mice were randomized to four groups: unirradiated control, conventional irradiation of entire tumor, GRID therapy, and hemi-irradiation (half-beam block, 50% tumor volume treated). All irradiated mice received a single fraction of 15 Gy. Results . High peak-to-valley ratios were achieved (bar GRIDs: 11.9 ± 0.9, 13.6 ± 0.4, 13.8 ± 0.5; pencil-beam GRIDs: 18.7 ± 0.6, 26.3 ± 1.5, 31.0 ± 3.3). Pencil-beam GRIDs could theoretically spare more intra-tumor immune cells than bar GRIDs, but they treat less tumor tissue (3%–4% versus 19%–23% area receiving 90% prescription, respectively). Bar GRID and hemi-irradiation treatments significantly delayed tumor growth ( P < 0.05), but not as much as a conventional treatment ( P < 0.001). No significant difference was found in tumor growth delay between GRID and hemi-irradiation. Significance . High peak-to-valley ratios were achieved with kV grids: two-to-five times higher than values reported in literature for MV grids. GRID irradiation and hemi-irradiation delayed tumor growth, but neither was as effective as conventional whole tumor uniform dose treatment. Single fraction GRID therapy could not initiate an anti-cancer immune response strong enough to match conventional RT outcomes, but follow-up studies will evaluate the combination of mini-GRID with immune checkpoint blockade.
- 18 February 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (4) , 045017
An investigation of kV mini-GRID spatially fractionated radiation therapy: dosimetry and preclinical trial
Objective . To develop and characterize novel methods of extreme spatially fractionated kV radiation therapy (including mini-GRID therapy) and to evaluate efficacy in the context of a pre-clinical mouse study. Approach . Spatially fractionated GRIDs were precision-milled from 3 mm thick lead sheets compatible with mounting on a 225 kVp small animal irradiator (X-Rad). Three pencil-beam GRIDs created arrays of 1 mm diameter beams, and three ‘bar’ GRIDs created 1 × 20 mm rectangular fields. GRIDs projected 20 × 20 mm 2 fields at isocenter, and beamlets were spaced at 1, 1.25, and 1.5 mm, respectively. Peak-to-valley ratios and dose distributions were evaluated with Gafchromic film. Syngeneic transplant tumors were induced by intramuscular injection of a soft tissue sarcoma cell line into the gastrocnemius muscle of C57BL/6 mice. Tumor-bearing mice were randomized to four groups: unirradiated control, conventional irradiation of entire tumor, GRID therapy, and hemi-irradiation (half-beam block, 50% tumor volume treated). All irradiated mice received a single fraction of 15 Gy. Results . High peak-to-valley ratios were achieved (bar GRIDs: 11.9 ± 0.9, 13.6 ± 0.4, 13.8 ± 0.5; pencil-beam GRIDs: 18.7 ± 0.6, 26.3 ± 1.5, 31.0 ± 3.3). Pencil-beam GRIDs could theoretically spare more intra-tumor immune cells than bar GRIDs, but they treat less tumor tissue (3%–4% versus 19%–23% area receiving 90% prescription, respectively). Bar GRID and hemi-irradiation treatments significantly delayed tumor growth ( P < 0.05), but not as much as a conventional treatment ( P < 0.001). No significant difference was found in tumor growth delay between GRID and hemi-irradiation. Significance . High peak-to-valley ratios were achieved with kV grids: two-to-five times higher than values reported in literature for MV grids. GRID irradiation and hemi-irradiation delayed tumor growth, but neither was as effective as conventional whole tumor uniform dose treatment. Single fraction GRID therapy could not initiate an anti-cancer immune response strong enough to match conventional RT outcomes, but follow-up studies will evaluate the combination of mini-GRID with immune checkpoint blockade.
- 3 September 2019
- Published by Wiley in Medical Physics
- Vol. 46 (12) , 5758-5769
An investigation of a novel reusable radiochromic sheet for 2D dose measurement
Purpose: Radiochromic film remains a useful and versatile clinical dosimetry tool. Current film options are single use. Here, we introduce a novel prototype two‐dimensional (2D) radiochromic sheet, which optically clears naturally at room temperature after irradiation and can be reused. We evaluate the sheets for potential as a 2D dosimeter and as a radiochromic bolus with capability for dose measurement.Methods: A novel derivative of reusable Presage® was manufactured into thin sheets of 5 mm thickness. The sheets contained 2% cumin‐leucomalachitegreen‐diethylamine (LMG‐DEA) and plasticizer (up to 25% by weight). Irradiation experiments were performed to characterize the response to megavoltage radiation, including dose sensitivity, temporal decay rate, consistency of repeat irradiations, intra and inter‐sheet reproducibility, multi‐modality response (electrons and photons), and temperature sensitivity (22°C to 36°C). The local change in optical‐density (ΔOD), before and after radiation, was obtained with a flat‐bed film scanner and extracting the red channel. Repeat scanning enabled investigation of the temporal decay of ΔOD. Additional studies investigated clinical utility of the sheets through application to IMRT treatment plans (prostate and a TG119 commissioning plan), and a chest wall electron boost treatment. In the latter test, the sheet performed as a radiochromic bolus.Results: The radiation induced OD change in the sheets was found to be proportional to dose and to exponentially decay to baseline in ~24 h (R2 = 0.9986). The sheet could be reused and had similar sensitivity (within 1% after the first irradiation) for at least eight irradiations. Importantly, no memory of previous irradiations was observed within measurement uncertainty. The consistency of dose response from photons (6 and 15 MV) and electrons (6–20 MeV) was found to be within calibration uncertainty (~1%). The dose sensitivity of the sheets had a temperature dependence of 0.0012 ΔOD/°C. For the short (1 min) single field IMRT QA verification, good agreement was observed between the Presage sheet and EBT film (gamma pass rate 97% at 3% 3 mm dose‐difference and distance‐to‐agreement tolerance, with a 10% threshold). For the longer (~13 min) TG‐119 9‐field IMRT verification the gamma agreement was lower at 93% pass rate at 5% 3 mm, 10% threshold, when compared with Eclipse. The lower rate is attributed to uncertainty arising from signal decay during irradiation and indicates a current limitation. For the electron cutout treatment, both Presage and EBT agreed well (within 2% RMS difference) but differed from the Eclipse treatment plan (~7% RMS difference) indicating some limitations to the Eclipse modeling in this case. The worst case estimates of uncertainty introduced by the signal decay for deliveries of 2, 5, and 10 min are 0.6%, 1.4%, and 2.8% respectively.Conclusions: Reusable Presage sheets show promise for 2D dose measurement and as a radiochromic bolus for in vivo dose measurement. The current prototype is suitable for deliveries of length up to 5 min, where the uncertainty introduced by signal decay is anticipated to be ~1% (worst case 1.4%), or for longer deliveries where there is no temporal modulation (e.g. physical compensators, or open beams). Additionally, spatial resolution is limited by sheet thickness and scanner resolution, resulting in a practical resolution of 0.8 mm.
- 3 September 2019
- Published by Wiley in Medical Physics
- Vol. 46 (12) , 5758-5769
An investigation of a novel reusable radiochromic sheet for 2D dose measurement
Purpose: Radiochromic film remains a useful and versatile clinical dosimetry tool. Current film options are single use. Here, we introduce a novel prototype two‐dimensional (2D) radiochromic sheet, which optically clears naturally at room temperature after irradiation and can be reused. We evaluate the sheets for potential as a 2D dosimeter and as a radiochromic bolus with capability for dose measurement.Methods: A novel derivative of reusable Presage® was manufactured into thin sheets of 5 mm thickness. The sheets contained 2% cumin‐leucomalachitegreen‐diethylamine (LMG‐DEA) and plasticizer (up to 25% by weight). Irradiation experiments were performed to characterize the response to megavoltage radiation, including dose sensitivity, temporal decay rate, consistency of repeat irradiations, intra and inter‐sheet reproducibility, multi‐modality response (electrons and photons), and temperature sensitivity (22°C to 36°C). The local change in optical‐density (ΔOD), before and after radiation, was obtained with a flat‐bed film scanner and extracting the red channel. Repeat scanning enabled investigation of the temporal decay of ΔOD. Additional studies investigated clinical utility of the sheets through application to IMRT treatment plans (prostate and a TG119 commissioning plan), and a chest wall electron boost treatment. In the latter test, the sheet performed as a radiochromic bolus.Results: The radiation induced OD change in the sheets was found to be proportional to dose and to exponentially decay to baseline in ~24 h (R2 = 0.9986). The sheet could be reused and had similar sensitivity (within 1% after the first irradiation) for at least eight irradiations. Importantly, no memory of previous irradiations was observed within measurement uncertainty. The consistency of dose response from photons (6 and 15 MV) and electrons (6–20 MeV) was found to be within calibration uncertainty (~1%). The dose sensitivity of the sheets had a temperature dependence of 0.0012 ΔOD/°C. For the short (1 min) single field IMRT QA verification, good agreement was observed between the Presage sheet and EBT film (gamma pass rate 97% at 3% 3 mm dose‐difference and distance‐to‐agreement tolerance, with a 10% threshold). For the longer (~13 min) TG‐119 9‐field IMRT verification the gamma agreement was lower at 93% pass rate at 5% 3 mm, 10% threshold, when compared with Eclipse. The lower rate is attributed to uncertainty arising from signal decay during irradiation and indicates a current limitation. For the electron cutout treatment, both Presage and EBT agreed well (within 2% RMS difference) but differed from the Eclipse treatment plan (~7% RMS difference) indicating some limitations to the Eclipse modeling in this case. The worst case estimates of uncertainty introduced by the signal decay for deliveries of 2, 5, and 10 min are 0.6%, 1.4%, and 2.8% respectively.Conclusions: Reusable Presage sheets show promise for 2D dose measurement and as a radiochromic bolus for in vivo dose measurement. The current prototype is suitable for deliveries of length up to 5 min, where the uncertainty introduced by signal decay is anticipated to be ~1% (worst case 1.4%), or for longer deliveries where there is no temporal modulation (e.g. physical compensators, or open beams). Additionally, spatial resolution is limited by sheet thickness and scanner resolution, resulting in a practical resolution of 0.8 mm.
- Open Access
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012019
Preliminary characterization of the Duke Integrated-Lens Optical-CT scanner (DIOS)
The present study investigates a cost effective and practical non-telecentric optical-CT scanner developed for 3D dosimetry, the Duke Integrated-Lens Optical-CT scanner (DIOS). The DIOS system includes an upgraded light-collimating tank (the LC-tank) made of solid polyurethane with precision curved ends (with lensing functionality) and a precision cylindrical central hollow for the dosimeter. The LC-tank thus collimates light from a small area light source (~2cm diameter) into parallel rays through the dosimeter, with refocusing of emergent light onto a CCD camera with a focusing lens with an aperture. The solid nature of the LC-Tank dramatically reduces the amount of required refractive matching fluid compared to earlier scanning systems. The aim of this work was to perform preliminary characterization studies of DIOS in comparison to earlier systems, particularly telecentric systems. The preliminary results indicate promising performance for the DIOS approach.
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012019
Open AccessPreliminary characterization of the Duke Integrated-Lens Optical-CT scanner (DIOS)
The present study investigates a cost effective and practical non-telecentric optical-CT scanner developed for 3D dosimetry, the Duke Integrated-Lens Optical-CT scanner (DIOS). The DIOS system includes an upgraded light-collimating tank (the LC-tank) made of solid polyurethane with precision curved ends (with lensing functionality) and a precision cylindrical central hollow for the dosimeter. The LC-tank thus collimates light from a small area light source (~2cm diameter) into parallel rays through the dosimeter, with refocusing of emergent light onto a CCD camera with a focusing lens with an aperture. The solid nature of the LC-Tank dramatically reduces the amount of required refractive matching fluid compared to earlier scanning systems. The aim of this work was to perform preliminary characterization studies of DIOS in comparison to earlier systems, particularly telecentric systems. The preliminary results indicate promising performance for the DIOS approach.
- Open Access
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012024
SRS and SBRT and advanced dosimetry: Duke experiences
Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are among the most demanding of radiation therapy techniques in terms of requirements for high accuracy and conformality of treatment delivery. Compared to conventional treatments, they require specialized high-precision equipment (including high specification medical accelerators and alignment frames), extensive imaging (including multi-modal and motion management methods), specialized Quality Assurance protocols, and increased person-power effort. In addition, the high dose-per-fraction renders SRS/SBRT a high-stakes treatment setting, where small errors may cause significant treatment morbidity in normal healthy tissue. All of these issues combine to render SRS/SBRT one of the most opportunistically rich and clinically important areas for advanced dosimetry research. Some of the applications of advanced 3D dosimetry to SRS and SBRT and small field treatment verification are explored. Applications include base of skull IMRT, single-isocenter multi-lesion radiosurgery, pre-clinical precision treatments, interpreting the clinical significance of 3D QA data, remote dosimetry, dosimetry in magnetic fields, trigeminal neuralgia, rodent-morphic dosimetry, motion, and small field commissioning.
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012024
Open AccessSRS and SBRT and advanced dosimetry: Duke experiences
Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are among the most demanding of radiation therapy techniques in terms of requirements for high accuracy and conformality of treatment delivery. Compared to conventional treatments, they require specialized high-precision equipment (including high specification medical accelerators and alignment frames), extensive imaging (including multi-modal and motion management methods), specialized Quality Assurance protocols, and increased person-power effort. In addition, the high dose-per-fraction renders SRS/SBRT a high-stakes treatment setting, where small errors may cause significant treatment morbidity in normal healthy tissue. All of these issues combine to render SRS/SBRT one of the most opportunistically rich and clinically important areas for advanced dosimetry research. Some of the applications of advanced 3D dosimetry to SRS and SBRT and small field treatment verification are explored. Applications include base of skull IMRT, single-isocenter multi-lesion radiosurgery, pre-clinical precision treatments, interpreting the clinical significance of 3D QA data, remote dosimetry, dosimetry in magnetic fields, trigeminal neuralgia, rodent-morphic dosimetry, motion, and small field commissioning.
- Open Access
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012032
Preliminary investigation of a reusable radiochromic sheet for radiation dosimetry
This work investigates a novel reusable radiochromic sheet developed as an economic film substitute or as a radiochromic bolus. The radiation-induced optical density (OD) change of the sheet is read-out with a commercial flat-bed optical scanner. An optimized readout procedure was developed including an optimal scan-time window. Fundamental radiochromic properties of the sheets were characterized including temporal decay of OD, dose sensitivity and consistency through repeated irradiations, and temperature sensitivity. The radiation induced OD change in the sheets was found to decay to baseline within ~24 hours, after which the sheet could be reused. The sensitivity of subsequent re-irradiations was found to be consistent within ±5% (coefficient of variation of 4.5%) for at least 6 irradiations and potentially many more. Importantly, the sheets were not observed to carry any detectable memory of previous irradiations within measurement uncertainty. In conclusion, the Presage sheets show promise as an economic multi-purpose alternative for film applications and potentially as a radiochromic bolus. Further work is required to test the sheet in diverse clinical applications, and to develop a softer material for bolus applications.
- 1 August 2019
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1305 (1) , 012032
Open AccessPreliminary investigation of a reusable radiochromic sheet for radiation dosimetry
This work investigates a novel reusable radiochromic sheet developed as an economic film substitute or as a radiochromic bolus. The radiation-induced optical density (OD) change of the sheet is read-out with a commercial flat-bed optical scanner. An optimized readout procedure was developed including an optimal scan-time window. Fundamental radiochromic properties of the sheets were characterized including temporal decay of OD, dose sensitivity and consistency through repeated irradiations, and temperature sensitivity. The radiation induced OD change in the sheets was found to decay to baseline within ~24 hours, after which the sheet could be reused. The sensitivity of subsequent re-irradiations was found to be consistent within ±5% (coefficient of variation of 4.5%) for at least 6 irradiations and potentially many more. Importantly, the sheets were not observed to carry any detectable memory of previous irradiations within measurement uncertainty. In conclusion, the Presage sheets show promise as an economic multi-purpose alternative for film applications and potentially as a radiochromic bolus. Further work is required to test the sheet in diverse clinical applications, and to develop a softer material for bolus applications.
- 1 March 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 100 (3) , 794-801
Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy
- 1 March 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 100 (3) , 794-801
Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy
- 9 October 2017
- Published by Wiley in Medical Physics
- Vol. 44 (11) , 6018-6028
Development of a 3D remote dosimetry protocol compatible with MRgIMRT
- 9 October 2017
- Published by Wiley in Medical Physics
- Vol. 44 (11) , 6018-6028
Development of a 3D remote dosimetry protocol compatible with MRgIMRT
- 24 August 2017
- Published by Wiley in Medical Physics
- Vol. 44 (11) , 6008-6017
A precision 3D conformal treatment technique in rats: Application to whole‐brain radiotherapy with hippocampal avoidance
Purpose: To develop and validate three‐dimensional (3D) conformal hippocampal sparing whole‐brain radiation therapy (HA‐WBRT) for Wistar rats utilizing precision 3D‐printed immobilization and micro‐blocks. This technique paves the way for future preclinical studies investigating brain treatments that reduce neurotoxicity.Methods and materials: A novel preclinical treatment planning and delivery process was developed to enable precision 3D conformal treatment and hippocampal avoidance capability for the Xrad 225cx small animal irradiator. A range of conformal avoidance plans were evaluated consisting of equiangularly spaced coplanar axial beams, with plans containing 2, 4, 7, and 8 fields. The hippocampal sparing and coverage of these plans were investigated through Monte Carlo dose calculation (SmART‐Plan Xrad 225cx planning system). Treatment delivery was implemented through a novel process where hippocampal block shapes were computer generated from an MRI rat atlas which was registered to on‐board cone beam CT of the rat in treatment position. The blocks were 3D printed with a tungsten‐doped filament at lateral resolution of 80 μm. Precision immobilization was achieved utilizing a 3D‐printed support system which enabled angled positioning of the rat head in supine position and bite block to improve coverage of the central diencephalon. Treatment delivery was verified on rodent‐morphic Presage® 3D dosimeters optically scanned at 0.2‐mm isotropic resolution. Biological verification of hippocampal avoidance was performed with immunohistologic staining.Results: All simulated plans spared the hippocampus while delivering high dose to the brain (22.5–26.2 Gy mean dose to brain at mean hippocampal dose of 7 Gy). No significant improvement in hippocampal sparing was observed by adding beams beyond four fields. Dosimetric sparing of hippocampal region of the four‐field plan was verified with the Presage® dosimeter (mean dose = 9.6 Gy, D100% = 7.1 Gy). Simulation and dosimeter match at distance‐to‐agreement of 2 mm and dose difference of ±3% at 91.7% gamma passing rate (passing criteria of γ < 1). Agreement is less at 1 mm and ±5% at 69.0% gamma passing rate. The four‐field plan was further validated with immunohistochemistry and showed a significant reduction in DNA double‐strand breaks within the spared region compared with whole‐brain irradiated groups (P = 0.021). However, coverage of the whole brain was low at 48.5–57.8% of the volume receiving 30Gy at 7Gy mean hippocampal dose in simulation and 46.7–52.5% in dosimetric measurements. This can be attributed to the shape of the rat hippocampus and the inability of treatment platform to employ non‐coplanar beams.Conclusion: A novel approach for conformal microradiation therapy using 3D‐printing technology was developed, implemented, and validated. A workflow was developed to generate accurate 3D‐printed blocks from registered high‐resolution rat MRI atlas structures. Although hippocampus was spared with this technique, whole‐brain target coverage was suboptimal, indicating that non‐coplanar beams and IMRT capability may be required to meet stringent dose criteria associated with current human RTOG trials.
- 24 August 2017
- Published by Wiley in Medical Physics
- Vol. 44 (11) , 6008-6017
A precision 3D conformal treatment technique in rats: Application to whole‐brain radiotherapy with hippocampal avoidance
Purpose: To develop and validate three‐dimensional (3D) conformal hippocampal sparing whole‐brain radiation therapy (HA‐WBRT) for Wistar rats utilizing precision 3D‐printed immobilization and micro‐blocks. This technique paves the way for future preclinical studies investigating brain treatments that reduce neurotoxicity.Methods and materials: A novel preclinical treatment planning and delivery process was developed to enable precision 3D conformal treatment and hippocampal avoidance capability for the Xrad 225cx small animal irradiator. A range of conformal avoidance plans were evaluated consisting of equiangularly spaced coplanar axial beams, with plans containing 2, 4, 7, and 8 fields. The hippocampal sparing and coverage of these plans were investigated through Monte Carlo dose calculation (SmART‐Plan Xrad 225cx planning system). Treatment delivery was implemented through a novel process where hippocampal block shapes were computer generated from an MRI rat atlas which was registered to on‐board cone beam CT of the rat in treatment position. The blocks were 3D printed with a tungsten‐doped filament at lateral resolution of 80 μm. Precision immobilization was achieved utilizing a 3D‐printed support system which enabled angled positioning of the rat head in supine position and bite block to improve coverage of the central diencephalon. Treatment delivery was verified on rodent‐morphic Presage® 3D dosimeters optically scanned at 0.2‐mm isotropic resolution. Biological verification of hippocampal avoidance was performed with immunohistologic staining.Results: All simulated plans spared the hippocampus while delivering high dose to the brain (22.5–26.2 Gy mean dose to brain at mean hippocampal dose of 7 Gy). No significant improvement in hippocampal sparing was observed by adding beams beyond four fields. Dosimetric sparing of hippocampal region of the four‐field plan was verified with the Presage® dosimeter (mean dose = 9.6 Gy, D100% = 7.1 Gy). Simulation and dosimeter match at distance‐to‐agreement of 2 mm and dose difference of ±3% at 91.7% gamma passing rate (passing criteria of γ < 1). Agreement is less at 1 mm and ±5% at 69.0% gamma passing rate. The four‐field plan was further validated with immunohistochemistry and showed a significant reduction in DNA double‐strand breaks within the spared region compared with whole‐brain irradiated groups (P = 0.021). However, coverage of the whole brain was low at 48.5–57.8% of the volume receiving 30Gy at 7Gy mean hippocampal dose in simulation and 46.7–52.5% in dosimetric measurements. This can be attributed to the shape of the rat hippocampus and the inability of treatment platform to employ non‐coplanar beams.Conclusion: A novel approach for conformal microradiation therapy using 3D‐printing technology was developed, implemented, and validated. A workflow was developed to generate accurate 3D‐printed blocks from registered high‐resolution rat MRI atlas structures. Although hippocampus was spared with this technique, whole‐brain target coverage was suboptimal, indicating that non‐coplanar beams and IMRT capability may be required to meet stringent dose criteria associated with current human RTOG trials.